Dow ends up more than 300 points, buoyed by M&A and vaccine optimism

Automatic TRANSCRIPT

Stocks arising amid a slew of corporate deal making news in vaccine optimism AstraZeneca's resuming clinical trials for his Corona virus vaccine candidate following a brief pause after a patient experienced an unexplained illness Advisers CEO said that the drug maker would have key results from his vaccine candidate It's developing in

Coming up next